Extended-Interval Prophylaxis with Recombinant Factor IX FC Fusion Protein (rFIXFc) in Adults/Adolescents with Haemophilia B: Interim Results of the B-YOND Extension Study

被引：0
|
作者：
Mahlangu, J. [1 ,2 ]
Shapiro, A. D. [3 ]
Pasi, K. J. [4 ]
Ragni, M. V. [5 ]
Ozelo, M. C. [6 ]
Oldenburg, J. [7 ]
Matsushita, T. [8 ]
Baker, R. I. [9 ]
Yuan, H. [10 ]
Ramirez-Santiago, A. [10 ]
Pierce, G. F. [10 ]
Allen, G. [10 ]
Mei, B. [10 ]
机构：
[1] Univ Witwatersrand, Fac Hlth Sci, Haemophilia Comprehens Care Ctr, Johannesburg, South Africa
[2] NHLS, Johannesburg, South Africa
[3] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA
[4] Barts & London Queen Marys Sch Med & Dent, Royal London Haemophilia Ctr, London, England
[5] Univ Pittsburgh, Hemophilia Ctr Western Penn, Pittsburgh, PA USA
[6] Univ Estadual Campinas, INCT Sangue Hemoctr UNICAMP, Campinas, SP, Brazil
[7] Univ Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
[8] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan
[9] Murdoch Univ, Western Australia Ctr Thrombosis & Haemostasis, Perth, WA, Australia
[10] Biogen, Cambridge, MA USA
来源：
HAEMOPHILIA | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P044
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [1] Individualised Prophylaxis with Recombinant Factor IX FC Fusion Protein (RFIXFC) in Adults/Adolescents With Haemophilia B: Updated Interim Results of the B-YOND Extension Study
    Mahlangu, J. N.
    Shapiro, A. D.
    Pasi, K. J.
    Ragni, M. V.
    Ozelo, M. C.
    Oldenburg, J.
    Matsushita, T.
    Baker, R. I.
    Yuan, H.
    Ferrante, F.
    Ramirez-Santiago, A.
    Lethagen, S.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 85 - 86
  • [2] Individualised Prophylaxis In Children With Haemophilia B Treated Long Term With Recombinant Factor Ix Fc Fusion Protein (RFIXFC): Updated Interim Results Of The B-YOND Extension Study
    Fischer, K.
    Kulkarni, R.
    Nolan, B.
    Bennett, C. M.
    Perry, D. J.
    Barnes, C.
    Yuan, H.
    Ramirez-Santiago, A.
    Ferrante, F.
    Dumont, J.
    Lethagen, S.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 94 - 94
  • [3] Clinical Outcomes in Adults/Adolescents with Hemophilia B Treated Long Term with Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-Yond Extension Study
    Matsushita, Tadashi
    Mahlangu, Johnny
    Shapiro, Amy D.
    Pasi, K. John
    Ragni, Margaret V.
    Ozelo, Margareth C.
    Oldenburg, Johannes
    Baker, Ross I.
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Ferrante, Francesca
    Lethagen, Stefan
    BLOOD, 2016, 128 (22)
  • [4] Clinical Outcomes in Children with Haemophilia B Treated Long Term with Recombinant Factor IX FC Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-YOND Extension Study
    Fischer, K.
    Kulkarni, R.
    Nolan, B.
    Bennett, C. M.
    Perry, D. J.
    Barnes, C.
    Yuan, H.
    Ramirez-Santiago, A.
    Pierce, G. F.
    Mei, B.
    HAEMOPHILIA, 2016, 22 : 47 - 48
  • [5] Extended-Interval Prophylaxis with rFIXFc in Adults and Adolescents with Hemophilia B: Interim Results of the B- YOND Extension Study
    Mahlangu, Johnny
    Shapiro, Amy D.
    Pasi, K. John
    Ragni, Margaret V.
    Ozelo, Margareth Castro
    Oldenburg, Johannes
    Matsushita, Tadashi
    Baker, Ross I.
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Pierce, Glenn F.
    Allen, Geoffrey
    Mei, Baisong
    BLOOD, 2015, 126 (23)
  • [6] Long Term Safety and Efficacy of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis in Children with Hemophilia B: Interim Results of the B-Yond Extension Study
    Ducore, Jonathan M.
    Fischer, Kathelijn
    Kulkarni, Roshni
    Nolan, Beatrice
    Bennett, Carolyn M.
    Perry, David J.
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Ferrante, Francesca
    Lethagen, Stefan
    BLOOD, 2016, 128 (22)
  • [7] Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B
    Pasi, K. John
    Fischer, Kathelijn
    Ragni, Margaret
    Nolan, Beatrice
    Perry, David J.
    Kulkarni, Roshni
    Ozelo, Margareth
    Mahlangu, Johnny
    Shapiro, Amy D.
    Baker, Ross I.
    Bennett, Carolyn M.
    Barnes, Christopher
    Oldenburg, Johannes
    Matsushita, Tadashi
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Pierce, Glenn F.
    Allen, Geoffrey
    Mei, Baisong
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (03) : 508 - 518
  • [8] Long-term safety and efficacy of recombinant factor IX Fc fusion protein (rFIXFc) in adults/adolescents with hemophilia B: Longitudinal analysis of B-LONG and B-YOND
    Mahlangu, Johnny
    Ragni, Margaret V.
    Shapiro, Amy D.
    Pasi, K. John
    Ozelo, Margareth C.
    Oldenburg, Johannes
    Matsushita, Tadashi
    Baker, Ross I.
    Feng, Ingyuan
    Ferrante, Francesca
    Ramirez-Santiago, Alejandra
    Mei, Baisong
    Barnowski, Chris
    HAEMOPHILIA, 2016, 22 : 47 - 47
  • [9] Long-Term Safety and Efficacy of Recombinant Factor Ix Fc (rFIXFc) for Treatment of Severe Haemophilia B: European Subgroup Interim Analysis of the B-YOND Study
    Chambost, H.
    Perry, D.
    Holmstrom, M.
    Hermans, C.
    Ferrante, F.
    Szamosi, J.
    Lethagen, S.
    HAEMOPHILIA, 2017, 23 : 69 - 70
  • [10] Long-term Efficacy of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis in Adults, Adolescents, and Children With Hemophilia B: Longitudinal Analysis of B-LONG, Kids B-LONG, and B-YOND
    Kulkarni, R.
    Ragni, M.
    Mahlangu, J.
    Shapiro, A.
    Oldenburg, J.
    Matsushita, T.
    Nolan, B.
    Feng, J.
    Winding, B.
    Ramirez-Santiago, A.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 23 - 24
12345